Performance Evaluation of the Gradient Diffusion Strip Method and Disk Diffusion Method for Ceftazidime–Avibactam Against Enterobacterales and Pseudomonas aeruginosa: A Dual-Center Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Performance Evaluation of the Gradient Diffusion Strip Method and Disk Diffusion Method for Ceftazidime–Avibactam Against Enterobacterales and Pseudomonas aeruginosa: A Dual-Center Study
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-16
DOI
10.3389/fmicb.2021.710526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Klebsiella pneumoniae KPC producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene
- (2020) Elisa Antinori et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China
- (2020) Qi Wang et al. BMC MICROBIOLOGY
- Evaluation of Modified Rapid Carbapenem Inactivation Method (mrCIM) Combined with Rapid EDTA-Modified Carbapenem Inactivation Method (reCIM) to Detect Carbapenemase and Distinguish Metallo-Carbapenemase in Enterobacteriaceae Within Four Hours
- (2020) Qiang Wei et al. Infection and Drug Resistance
- In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa: Results from a Multicenter Study in China, 2017
- (2019) Dandan Yin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
- (2019) Stephan Göttig et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015
- (2018) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
- (2018) Matt Shirley DRUGS
- Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae
- (2018) Barbara A. Santevecchi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae
- (2018) Hervé Boutal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of ceftazidime-avibactam and aztreonam-avibactam against OXA-48-carrying Enterobacteriaceae isolated as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance program, 2012 to 2015
- (2018) Krystyna M. Kazmierczak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Loss of activity of ceftazidime-avibactam due to Mex-AB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis
- (2018) Hussein Chalhoub et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms
- (2018) E Wenzler et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
- (2018) Wenxia Zhang et al. Antimicrobial Resistance and Infection Control
- Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
- (2017) Rong Zhang et al. EBioMedicine
- Assessment of theIn VitroActivity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014
- (2016) Meredith Hackel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)
- (2016) Wright W. Nichols et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
- (2015) T. Tängdén et al. JOURNAL OF INTERNAL MEDICINE
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current Challenges in Antimicrobial Chemotherapy
- (2010) Carine Bebrone et al. DRUGS
- Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance in Pseudomonas aeruginosa
- (2009) A. Dotsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now